Detalhe da pesquisa
1.
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.
Eur J Haematol
; 104(5): 400-408, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804029
2.
A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group.
Am J Hematol
; 93(7): 867-873, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658143
3.
HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.
Blood
; 122(8): 1448-54, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23843497
4.
Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure.
Transfusion
; 55(4): 875-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25354577
5.
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
Br J Haematol
; 159(3): 322-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23016878
6.
Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach.
Haematologica
; 97(3): 464-71, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058202
7.
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
J Clin Oncol
; 40(11): 1196-1205, 2022 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030036
8.
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
Clin Lymphoma Myeloma Leuk
; 22(7): 483-494, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078739
9.
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
J Hematol Oncol
; 14(1): 111, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34271963
10.
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.
Lancet Haematol
; 7(7): e511-e522, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589977
11.
Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Hematology
; 22(8): 484-492, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28415913
12.
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.
Cancer Med
; 6(11): 2507-2514, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28960797
13.
Tartrazina induce genotoxicidad en linfocitos de BALB/c Mus musculus / Tartrazine induces genotoxicity in BALB/c Mus musculus lymphocytes
Rev. peru. med. exp. salud publica
; 38(4): 587-594, oct.-dic. 2021. tab, graf
Artigo
em Espanhol
| LILACS | ID: biblio-1365918
14.
Prácticas y creencias sobre estilos de vida asociadas alíndice de masa corporal en enfermeros / Practices and beliefs about lifestyle associated with the body mass index in nurses
Cult. cuid. enferm
; 12(2): 31-42, dici.2015. tab
Artigo
em Espanhol
| LILACS, BDENF - enfermagem (Brasil) | ID: lil-785593
15.
Caracterización isoenzimatica de seis poblaciones de Annona cherimola Mill. de la Región La Libertad, Perú / Isoenzymic characterization of six populations of Annona cherimola Mill. from La Libertad Region, Peru
Rev. peru. biol. (Impr.)
; 16(2): 195-201, dic. 2009. ilus, tab
Artigo
em Espanhol
| LIPECS | ID: biblio-1111304